Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.

Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, Vogels A, van Amelsvoort T, Gothelf D, Weinberger R, Weizman A, Klaassen PW, Koops S, Kates WR, Antshel KM, Simon TJ, Ousley OY, Swillen A, Gur RE, Bearden CE, Kahn RS, Bassett AS; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

JAMA Psychiatry. 2015 Apr;72(4):377-85. doi: 10.1001/jamapsychiatry.2014.2671.

2.

Intellectual functioning in relation to autism and ADHD symptomatology in children and adolescents with 22q11.2 deletion syndrome.

Hidding E, Swaab H, de Sonneville LM, van Engeland H, Sijmens-Morcus ME, Klaassen PW, Duijff SN, Vorstman JA.

J Intellect Disabil Res. 2015 Sep;59(9):803-15. doi: 10.1111/jir.12187. Epub 2015 Feb 13.

PMID:
25683771
3.

Engineering of an endogenous hexose transporter into a specific D-xylose transporter facilitates glucose-xylose co-consumption in Saccharomyces cerevisiae.

Nijland JG, Shin HY, de Jong RM, de Waal PP, Klaassen P, Driessen AJ.

Biotechnol Biofuels. 2014 Nov 29;7(1):168. doi: 10.1186/s13068-014-0168-9. eCollection 2014.

4.

Behavioral phenotype in children with 22q11DS: agreement between parents and teachers.

Klaassen PW, Duijff SN, Sinnema G, Beemer FA, Swanenburg de Veye HF, Vorstman JA.

Psychol Assess. 2015 Mar;27(1):272-9. doi: 10.1037/a0038102. Epub 2014 Dec 1.

PMID:
25436664
5.

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Schneider M, Debbané M, Bassett AS, Chow EW, Fung WL, van den Bree M, Owen M, Murphy KC, Niarchou M, Kates WR, Antshel KM, Fremont W, McDonald-McGinn DM, Gur RE, Zackai EH, Vorstman J, Duijff SN, Klaassen PW, Swillen A, Gothelf D, Green T, Weizman A, Van Amelsvoort T, Evers L, Boot E, Shashi V, Hooper SR, Bearden CE, Jalbrzikowski M, Armando M, Vicari S, Murphy DG, Ousley O, Campbell LE, Simon TJ, Eliez S; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Am J Psychiatry. 2014 Jun;171(6):627-39. Review.

6.

Cognitive and behavioral trajectories in 22q11DS from childhood into adolescence: a prospective 6-year follow-up study.

Duijff SN, Klaassen PW, Swanenburg de Veye HF, Beemer FA, Sinnema G, Vorstman JA.

Res Dev Disabil. 2013 Sep;34(9):2937-45. doi: 10.1016/j.ridd.2013.06.001. Epub 2013 Jun 29.

PMID:
23816629
7.

Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.

Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, Higgins AM, Coleman K, Chow C, Jalbrzikowski M, Bearden CE, Bailey A, Vangkilde A, Olsen L, Olesen C, Skovby F, Werge TM, Templin L, Busa T, Philip N, Swillen A, Vermeesch JR, Devriendt K, Schneider M, Dahoun S, Eliez S, Schoch K, Hooper SR, Shashi V, Samanich J, Marion R, van Amelsvoort T, Boot E, Klaassen P, Duijff SN, Vorstman J, Yuen T, Silversides C, Chow E, Bassett A, Frisch A, Weizman A, Gothelf D, Niarchou M, van den Bree M, Owen MJ, Suñer DH, Andreo JR, Armando M, Vicari S, Digilio MC, Auton A, Kates WR, Wang T, Shprintzen RJ, Emanuel BS, Morrow BE.

Am J Hum Genet. 2013 Mar 7;92(3):439-47. doi: 10.1016/j.ajhg.2013.01.018. Epub 2013 Feb 28. Erratum in: Am J Hum Genet. 2013 Apr 4;92(4):637. Jarlbrzkowski, Maria [corrected to Jalbrzikowski, Maria].

8.

Behavior in preschool children with the 22q11.2 deletion syndrome.

Klaassen P, Duijff S, Swanenburg de Veye H, Vorstman J, Beemer F, Sinnema G.

Am J Med Genet A. 2013 Jan;161A(1):94-101. doi: 10.1002/ajmg.a.35685. Epub 2012 Dec 13.

PMID:
23239609
9.

Searching for microbial protein over-expression in a complex matrix using automated high throughput MS-based proteomics tools.

Akeroyd M, Olsthoorn M, Gerritsma J, Gutker-Vermaas D, Ekkelkamp L, van Rij T, Klaassen P, Plugge W, Smit E, Strupat K, Wenzel T, van Tilborg M, van der Hoeven R.

J Biotechnol. 2013 Mar 10;164(1):112-20. doi: 10.1016/j.jbiotec.2012.11.015. Epub 2012 Dec 5.

PMID:
23220267
10.

[Doege-Potter syndrome: hypoglycemia secondary to solitary fibrous tumor of the pleura. Report of one case].

Campos M R, González L R, Saldías F R, Klaassen P R, Alarcón C E.

Rev Med Chil. 2012 Mar;140(3):353-7. doi: 10.4067/S0034-98872012000300011. Spanish.

11.

Cognitive development in children with 22q11.2 deletion syndrome.

Duijff SN, Klaassen PW, de Veye HF, Beemer FA, Sinnema G, Vorstman JA.

Br J Psychiatry. 2012 Jun;200(6):462-8. doi: 10.1192/bjp.bp.111.097139.

12.

De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnology.

Nijkamp JF, van den Broek M, Datema E, de Kok S, Bosman L, Luttik MA, Daran-Lapujade P, Vongsangnak W, Nielsen J, Heijne WH, Klaassen P, Paddon CJ, Platt D, Kötter P, van Ham RC, Reinders MJ, Pronk JT, de Ridder D, Daran JM.

Microb Cell Fact. 2012 Mar 26;11:36. doi: 10.1186/1475-2859-11-36.

13.

Intelligence and visual motor integration in 5-year-old children with 22q11-deletion syndrome.

Duijff S, Klaassen P, Beemer F, Swanenburg de Veye H, Vorstman J, Sinnema G.

Res Dev Disabil. 2012 Mar-Apr;33(2):334-40. doi: 10.1016/j.ridd.2011.10.004. Epub 2011 Nov 24.

PMID:
22119678
14.

Degeneration of penicillin production in ethanol-limited chemostat cultivations of Penicillium chrysogenum: A systems biology approach.

Douma RD, Batista JM, Touw KM, Kiel JA, Krikken AM, Zhao Z, Veiga T, Klaassen P, Bovenberg RA, Daran JM, Heijnen JJ, van Gulik WM.

BMC Syst Biol. 2011 Aug 19;5:132. doi: 10.1186/1752-0509-5-132.

15.

Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Bassett AS, McDonald-McGinn DM, Devriendt K, Digilio MC, Goldenberg P, Habel A, Marino B, Oskarsdottir S, Philip N, Sullivan K, Swillen A, Vorstman J; International 22q11.2 Deletion Syndrome Consortium.

J Pediatr. 2011 Aug;159(2):332-9.e1. doi: 10.1016/j.jpeds.2011.02.039. Epub 2011 May 12. No abstract available.

16.

Results of treatment with telmisartan-amlodipine in hypertensive patients.

Littlejohn TW 3rd, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, Oigman W; Study Investigators.

J Clin Hypertens (Greenwich). 2009 Apr;11(4):207-13. doi: 10.1111/j.1751-7176.2009.00098.x.

PMID:
19614805
17.

Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.

Littlejohn TW 3rd, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, Oigman W; study investigators.

Postgrad Med. 2009 Mar;121(2):5-14. doi: 10.3810/pgm.2009.03.1972.

PMID:
19332958
18.

Exploring and dissecting genome-wide gene expression responses of Penicillium chrysogenum to phenylacetic acid consumption and penicillinG production.

Harris DM, van der Krogt ZA, Klaassen P, Raamsdonk LM, Hage S, van den Berg MA, Bovenberg RA, Pronk JT, Daran JM.

BMC Genomics. 2009 Feb 10;10:75. doi: 10.1186/1471-2164-10-75.

19.

Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone.

Pedersen WR, Klaassen PJ, Pedersen CW, Wilson JA, Harris KM, Goldenberg IF, Poulose AK, Mooney MR, Henry TD, Schwartz RS.

Am J Cardiol. 2008 May 1;101(9):1309-14. doi: 10.1016/j.amjcard.2007.12.033. Epub 2008 Mar 17.

PMID:
18435963
20.

Production of functionally active Penicillium chrysogenum isopenicillin N synthase in the yeast Hansenula polymorpha.

Gidijala L, Bovenberg RA, Klaassen P, van der Klei IJ, Veenhuis M, Kiel JA.

BMC Biotechnol. 2008 Mar 19;8:29. doi: 10.1186/1472-6750-8-29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk